DOES MATERNAL HSV-2 INFECTION INCREASE RISK OF INTRA-PARTUM TRANSMISSION OF HIV-1? Frances M Cowan, Jean Humphrey, Robert Ntozini, Kuda Mutasa, Peter Iliff.

Slides:



Advertisements
Similar presentations
HIV Counselling and Testing
Advertisements

The Connection Between STDs and HIV
Issues in Genital Herpes
Unit 6 Diagnosis & Follow-up of HIV Infection
Research activities in Orange Farm Bertran Auvert INSERM University of Versailles, France Country update meeting on scaling - up of male circumcision programmes.
Using longitudinal, population-based HIV surveillance to measure the real-world impacts of ART scale-up in KwaZulu- Natal, South Africa Frank Tanser Presentation.
Genital Herpes Prevention and Clinical Services: What Should Health Departments Do Now? H. Hunter Handsfield, M.D. University of Washington Public Health.
Laboratory Diagnosis of HSV Infection Peter Leone, MD Associate Professor of Medicine University of North Carolina.
HIV: THE GLOABAL AND INDIAN SCENARIO DR. KANUPRIYA CHATURVEDI DR. S.K CHATURVEDI.
Monica Gandhi MD, MPH Associate Professor and Women’s HIV Clinic provider, HIV/AIDS Division San Francisco General Hospital/ UCSF Safe Poz Love, U.S. Positive.
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
The hidden HIV epidemic: what do mathematical models tell us? The case of France Virginie Supervie, Jacques Ndawinz & Dominique Costagliola U943 Inserm.
PMTCT program in Arua Uganda Lessons learned after 5 years of experience Experts Roundtable June 2008 Geneva.
PROMISE Introduction to PROMISE Protocol May 6, 2009.
Curable versus incurable STDs. Objectives To describe the natural history and epidemiology of two curable STDs (i.e. syphilis and chlamydia) and two non-
Primarily by Linda Wallen, MD Edited May, 2005
HIV Testing CDC power point edited by M. Myers
Peripartum Valacyclovir Improves Markers of HIV-1 Disease Progression in Women Co-Infected with HSV-2: A Randomized Trial Alison C. Roxby, MD, MSc. July.
The HIV/AIDS Epidemic © 2013 John B. Pryor Illinois State University.
Purpose Provide concepts and latest research findings related to prevention of mother-to-child transmission of HIV (PMTCT) for application in the workplace.
A Collaborative Analysis of Data from Cohorts in Thailand, South Africa, Botswana, and the United Kingdom International Collaborative Study of Pediatric.
Presenter : Dr T. G. Nematadzira on behalf of The IMPAACT PROMISE 1077BF/1077FF Team Efficacy and Safety of Two Strategies to Prevent Perinatal HIV Transmission.
Inputs to a case-based HIV surveillance system. Objectives  Review HIV case definitions  Understand clinical and immunologic staging  Identify the.
Sexually Transmitted Diseases
Seroprevalence of HBV and HCV among Children in the Kilimanjaro Region, Tanzania Florida J. Muro, Suzanne P. Fiorillo, Christopher Odhiambo, Coleen K.
Prevention of Mother to Child Transmission of HIV
Long-term impact of a behaviour change intervention among young people in rural Mwanza, Tanzania: Results of a community randomised trial David Ross for.
The Effect of Syphilis Co-infection on Clinical Outcomes in HIV-Infected Persons The Effect of Syphilis Co-infection on Clinical Outcomes in HIV-Infected.
PMTCT Generic Training PackageModule 1Slide 1 Introduction to HIV/AIDS M O D U L E 1.
Future ART options for HIV-infected children exposed to maternal HAART Lee Kleynhans Experts Roundtable June 2008.
Pediatric ID Previous presentation by Susan Schuval, MD
Population-based impact of ART in high HIV prevalence settings Marie-Louise Newell Professor of Global Health Faculty of Medicine, Faculty of Social and.
PMTCT Prevention of Mother to Child Transmission Version Aug 2011.
Education and counseling make a difference to infant feeding practices and those feeding practices make a difference to infant mortality Naume Tavengwa.
1 Diagnosis of HIV Infection in Children HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
Impact of HSV-2 suppressive therapy with daily acyclovir on HIV-1 disease progression: a randomized placebo- controlled trial in Rakai, Uganda Steven J.
HSV-2 is associated with HIV acquisition among both placebo & vaccine recipients in the Step Study Ruanne V Barnabas, MBChB DPhil HIV Vaccine Trials Network,
HERPES SIMPLEX VIRUS. Characteristics of HSV DNA double stranded virus, linear Enveloped Virion size 200 nm, relatively big 9 HSVs, Ex. Varicella, EBV,
EARLY CHILDHOOD OUTCOMES AT THE BOTSWANA- BAYLOR CHILDREN’S CLINICAL CENTRE OF EXCELLENCE: A REPORT TO THE WHO TECHNICAL REFERENCE GROUP ON PEDIATRIC CARE.
PMTCT Presented by: Ms T. Nondanyana (PMTCT COORDINATOR) Room: 129 Tel:
Washington D.C., USA, July 2012www.aids2012.org Pregnancy and HIV Acquisition Nelly Mugo Kenyatta National Hospital/ University of Washington Hormonal.
1 Counseling and HIV Testing HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
CMV In Pregnancy Leili Chamani. MD. MPH. Specialist In Infectious Diseases Department Of Reproductive Health Avesina Research Center (ARC)
Eastern European Alliance for Reproductive Choice REPRODUCTIVE CHOICE FOR HIV- INFECTED WOMEN Prof. POSOKHOVA S.P. UKRAINE УКРАЇНАУКРАЇНА.
STD’s Sexually Transmitted Diseases. Alarming Sex Statistics In 2007, what % of high school students reported having had sexual intercourse. 48% What.
Preventing Sexually Transmitted Diseases Sexuality is an intrinsic part of human nature and affects many things People are not always honest about their.
Transmission of HIV from mother to fetus. - is not simply one of the major health problems today, but also a big problem in the field of human rights.
Alison Drake International AIDS Society Conference July 18, 2011 Valacyclovir suppression reduces breast milk and plasma HIV-1 RNA postpartum: results.
Session: 3 The four pronged approach to comprehensive prevention of HIV in infants and young children Dr.Pushpalatha, Assistant Professor, Dept of Pediatrics,
Human Immune Deficiency Virus Infection Dr Huda Taha Sep 2015.
Interventions for Clients with HIV/AIDS and Other Immunodeficiencies.
Estimating the Impact and Needs for Children and PMTCT Making sense: Understanding the numbers: from HIV surveillance to national and global HIV burden.
ICASA 2011 – Addis Ababa 1 Olayemi Matthew, MPH Institute of Human Virology Nigeria (IHVN) High HSV-2 prevalence among pregnant women in Nigeria and its.
Paz Bailey G 1, Sternberg M 1, Puren AJ 2, Markowitz LE 1, Ballard R 1, Delany S 3, Hawkes S 4, Nwanyanwu O 1, Ryan C 1, and Lewis DA 5 1. NCHHSTP, CDC.
Cascade of Prevention of Mother-to-Child Transmission of HIV (PMTCT) for Option B+ Transition: Findings from a Cohort of a Nationally Representative Sample.
Herpes Simplex Virus Type 2 infection among U.S. military service members: Public Health Implications and Opportunities for HIV Prevention Christian T.
HAART Initiation Within 2 Weeks of Seroconversion Associated With Virologic and Immunologic Benefits Slideset on: Hecht FM, Wang L, Collier A, et al. A.
HSV Prevention for STD Programs Where do we go from here? Pete Leone, MD Associate Professor of Medicine University of North Carolina Medical Director.
Identification of Potential Risk Factors for Mother-to- Infant HCV Transmission Slideset on: Mast EE, Hwang LY, Seto DS, et al. Risk factors for perinatal.
Provider Initiated HIV Counseling and Testing Unit 1: Introduction to HIV/AIDS.
Outcome of a Prevention of mother to child transmission (PMTCT ) programme following Implementation of prophylaxis for HIV infected pregnant women in Barbados:
 Efficacy of Nevirapine Administration on the Mother to Child Transmission of HIV using a modified HIVNET 012 regimen. M. A St John*, Alok Kumar*, Kelly.
Post natal integrated clubs as a way to improve retention in care of mother infant pairs in a primary care setting, Khayelitsha, South Africa. Aurélie.
CHILDREN and HIV.
SEXUALLY TRANSMITTED INFECTIONS
Module 4 (e) Pregnancy and Breast Feeding
Sarah Hawkes, Paz Bailey G, Sternberg M, Lewis DA and Puren A
Dorina Onoya1, Tembeka Sineke1, Alana Brennan1,2, Matt Fox1,2
مدیریت سندرومی بیماران آمیزشی مقدمه
Presentation transcript:

DOES MATERNAL HSV-2 INFECTION INCREASE RISK OF INTRA-PARTUM TRANSMISSION OF HIV-1? Frances M Cowan, Jean Humphrey, Robert Ntozini, Kuda Mutasa, Peter Iliff

Herpes simplex virus type 2 infection Role of HSV-2 on sexual acquisition and transmission of HIV How HSV-2 might effect intra-partum HIV transmission Zvitambo study Nested case control study to examine the role of HSV-2 in MTCT of HIV Implications

Herpes simplex virus type 2 - the cause of genital herpes Sexually transmitted Commonest cause of genital ulceration Infection may be symptomatic (65%) or asymptomatic (35%) Only one third of those infected are aware of diagnosis Following infection the virus becomes latent, periodically reactivating to cause recurrences. HIV and HSV-2 co-infection results in more frequent and severe recurrences Aciclovir suppresses genital herpes reactivation

What explains the variability in rates of HIV infection in Africa? 4 Cities Study – 2 cities in West Africa (low HIV prevalence) - 2 cities in East Africa (high HIV prevalence) AIDS 2001; 15: S15-30

Ndola HIV-1: 32% W, 24% M HSV-2: 55% W, 36% M Yaounde HIV-1: 7% W, 3.6% M HSV-2: 51% W, 27% M Kisumu HIV-1: 29% W, 18% M HSV-2: 68% W 35% M Cotonou HIV-1: 2.8% W, 2.8% M HSV-2: 30% W, 12% M

What explains the variability in rates of HIV infection in Africa? Circumcision HSV-2 infection  Sexual behavior not very different AIDS 2001; 15: S15-30

HSV-2 and sexual acquisition of HIV-1 Sexual acquisition of HIV-1 is likely increased by presence of HSV-2 infection (AIDS 2006) Meta-analysis of 19 studies suggests that prevalent HSV-2 infection increases risk of acquisition in men (adjusted RR 2.7 [95% CI ]) and women (aRR 3.1 [95% CI ]. Studies looking at effect of incident HSV-2 infection are less methodologically sound. Intervention trials ongoing to see if suppressing HSV-2 infection with antiviral drugs can reduce this risk. (HPTN 039 and Mwanza Herpes Trial)

Effect of HSV-2 on sexual transmission of HIV Much less data than for acquisition Very few studies on HIV transmission overall Relatively few events observed Risk factors: high viral load, more advanced HIV disease or primary disease, Genital Ulcer Disease Only one study which has looked at effect of HSV-2 on sexual transmission of HIV

HSV-2 and sexual transmission of HIV-1 Genital ulceration increases risk of transmission five fold Per contact risk = vs for those without genital ulceration, p=0.002 HSV-2 seropositivity per se not associated with increased transmission risk. Lancet 2001;357:

How does HSV-2 facilitate sexual HIV-1 transmission? Increased genital shedding of HIV from both clinical and sub-clinical HSV-2 lesions (JAIDS 2003; 33: AIDS 2002;16: ) Possibly by increasing HIV-1 plasma viral load (Nagot et al CROI. 2006)

Intra-partum transmission of HIV Maternal health Obstetric factors Infant prematurity Linear relationship between maternal plasma HIV-1 viral load and risk of transmission

Intra-partum transmission - 2 Role of STIs in intra-partum transmission unclear. Presumptive treatment of bacterial STIs does not reduce risk of intra-partum transmission. (Am J Ob Gyn 2005;185: ) No data on whether HSV-2 infection increases risk of intra-partum transmission of HIV-1 Clinical genital herpes during pregnancy is associated with increased transmission risk (adj OR 4.8 (95%CI ). (Obst Gynec 2005;186:1341-8)

Pre-ARV era MCTC rates ACTG % (95%CI ) European collaborative study % (95% CI %) Sub-Saharan Africa 35-50%

Rates of HSV-2 vary globally NHANES % of adults in the USA infected. Higher rates among women and African-American women. European studies show sero-prevalences of 2-6% (higher in Eastern Europe) Rates in sub-Saharan Africa are high

Seroprevalence of HSV-2 in Tanzania JID 1999; 179:16-24

DOES MATERNAL HSV-2 INFECTION INCREASE RISK OF INTRA-PARTUM TRANSMISSION OF HIV-1?

Zvitambo Study Randomised placebo controlled trial Aimed to discover if giving Vitamin A to mothers and babies in the immediate post-partum period i)improved infant mortality ii)reduced risk of mother to child transmission of HIV-1 through breast feeding iii)reduced the risk of women acquiring HIV-1 in the year after delivery. Recruitment took place in Harare, Zimbabwe from November 1997 to January 2000.

Trial design 14,110 mother-baby pairs recruited Included 4,495 HIV-1 positive mothers HIV-1 positive mothers and their babies had blood taken at baseline, 6 weeks, 3 months then 3 monthly for 2 years Where available specimens were archived from each visit

Objectives of nested case control study To see if: women with prevalent HSV-2 infection at delivery had an increased risk of intra-partum transmission of HIV-1; women who acquired HSV-2 antibodies within 6 weeks of delivery had an increased risk of intra- partum transmission of HIV-1; women with serological evidence of active syphilis at delivery had an increased risk of intra- partum transmission. Case control study using archived sera

Case control study design Cases: 509 HIV+ve women whose babies were presumed HIV infected intra-partum (baby HIV PCR-negative at delivery and PCR-positive at 6 weeks) Controls: 1018 HIV-positive women whose babies remained PCR-negative at 1 year

Power If 80% of controls group are co-infected with HSV-2, the study had > 90% power to detect a 50% increase in the risk of intra-partum transmission. If incidence of HSV-2 is 1% in the control arm the study has 80% power to show that incident HSV-2 increases the risk of intra-partum by a factor >3.

Testing strategy Maternal serum taken within 96 hours of delivery was tested for HSV-2 antibody –HerpeSelect (Focus Diagnostics) –Low +ves / indeterminates re-tested using HerpeSelect –Those remained LP/Ind re-tested using western blot (11%) –Those remained LP/Ind re-tested using Biokit Elisa –Random sample of positives and negatives retested using western blot and Biokit Elisa 6 week samples were tested for HSV-2 if HSV-2 seronegative at delivery and for syphilis (RPR and TPHA).

1527 women selected (509 cases and 1018 controls) Baseline FocusELISA 1127 positive 193 negative 4 indeterminate 162 low positive Retested by: Western blot & BioELISA 1195 positive 253 negative 4 indeterminate 34 low positive Final baseline result Missing Pos Neg Ind Total Missing Pos Neg Ind Total W es ter nb lot BIOELISA 18 cases and 23 controls insufficient baseline sample HSV-2 Testing Flowchart: determination of baseline HSV-2 result

Results Overall 82.5% [95% CI ] of (HIV positive) women were HSV-2 antibody positive Baseline Characteristics –Cases were less educated, and had more signs of advanced HIV-1 disease (lower CD4 count, lower haemoglobin, higher viral load, smaller arm circumference) and to have to lower birth weight babies than controls.

Effect of prevalent HSV-2 infection Cases were more likely than controls to be HSV-2 infected (unadj OR 1.49 [95% CI , p=0.01]) Cases were more likely than controls to be HSV-2 infected after adjusting for factors assoc d with intra- partum transmission (adj OR1.50 [95% CI , p=0.014]) The proportion of HIV-1 intra-partum transmission potentially attributable to maternal HSV-2 infection at time of delivery was 28.4% [95% CI ]

Sensitivity analyses Re-analysing data using differing testing algorithms for HSV-2 diagnosis did not change direction of effect but did alter significance of results HerpeSelect + WB only (unadj OR 1.27 [95% CI ], p=0.15, adj OR 1.28 [95% CI ], p=0.17). HerpeSelect + BioElisa only, (unadj OR 1.36 [95% CI ], p=0.03, adj OR 1.31 [95% CI ], p=0.08].

Effect of ‘incident’ HSV-2 infection 27 / 158 women who were HSV-2 negative at delivery had ‘seroconverted’ to HSV-2 by 6 weeks (17.3%, 95% CI ) ‘Sero-conversion’ was associated with an increased risk of HIV-1 transmission although not significant (unadj OR 1.59 [95% CI , p=0.29]; adj OR 1.44 [95% CI , p=0.44]

Effect of syphilis 52 of 1289 women had evidence of active syphilis at 6 weeks (4.0%, 95% CI ). Unadj OR of intra-partum transmission associated with syphilis = 0.89 [95% CI , p=0.68] Adj OR 0.63 [95% CI , p=0.16]

Conclusion HSV-2 is common among HIV positive women of child bearing age in Zimbabwe Maternal HSV-2 is associated with an increased the risk of intra-partum transmission of HIV Maternal seroconversion to HSV-2 is common and needs to be better defined. Syphilis is not associated with an increased risk of intra-partum transmission of HIV

Implications Adding HSV-2 interventions to existing PMTCT programmes might further reduce intra-partum transmission of HIV Unlikely to be worthwhile if using HAART but may have a significant impact where PMTCT uses nevaripine only approach Trial of adding suppressive aciclovir to nevaripine only PMTCT may be warranted?